(R)-2-(3-CHLOROPHENYL)-2-HYDROXYACETIC ACID, 95.0%, 5g

GC capillary column ROTI®Cap-5 HT, 15 m, 0.25 mm, 0.10 µm, 1 Piece(s)

4-Methylbenzyl Alcohol>99.0%(GC)100g

8-Chloro-3-methoxy-1,5-naphthyridine, 95.0%, 5g

Benzenesulfonamide, 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]-, 98%, 100mg

Tin(II) Chloride [for Perovskite precursor]>97.0%(T)5g

tert-Butyl (1-(((S)-1-((R)-3-benzyl-3-(1,2,2-trimethylhydrazinecarbonyl)piperidin-1-yl)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)amino)-2-methyl-1-oxopropan-2-yl)carbamate, 98%, 50mg

Methyl Methacrylate (stabilized with 6-tert-Butyl-2,4-xylenol), 99.8%, 25ml

(R)-2-Benzyl-4-(tert-butoxy)-4-oxobutanoic acid, 95.0%, 250mg

(R)-3-Ethylmorpholine, 95.0%, 5g

D-allo-Isoleucine Ethyl Ester Hydrochloride, 97.0%, 1g

(5-Chloro-1H-benzoimidazol-2-yl)-methanol, 95.0%, 5g

endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-ol, 98.0%, 10g